Poor sleep and elevation of liver function biomarkers may be predictive of liver cancer
1. Unhealthy sleep, as well elevations of liver enzymes and decreased levels of albumin and liver...
Read More
chronic-disease
Metformin Linked to Lower Risk of Cardiometabolic Diseases, Cardiometabolic Mortality, and All-Cause Mortality in Cancer Survivors
1. Among US cancer survivors, metformin was associated with a lower risk of cardiometabolic...
Read More
Serum interleukins may be elevated in patients with obsessive-compulsive disorder
1. Serum interleukin-1β (IL-1β) and interleukin-6 (IL-6) levels were higher in...
Read More
Comparison of hip fracture risk assessment tools for elderly patients
1. Femoral neck bone mineral density (FNBMD) alone discriminated 5-year hip fracture risk at least...
Read More
Subcutaneous amivantamab with lazertinib is non-inferior to intravenous administration, with fewer adverse reactions
1. Subcutaneous amivantamab combined with lazertinib was non-inferior to intravenous amivantamab...
Read More
Amivantamab and Lazertinib in Untreated EGFR-Mutated Advanced NSCLC
1. The progression-free survival between the amivantamab–lazertinib group (23.7 months) and the...
Read More
Anti-CD38 monoclonal antibody improves platelet counts in immune thrombocytopenia
1. In this randomized controlled trial, CM313, an anti-CD38 monoclonal antibody therapy, was...
Read More
APOE3 Christchurch heterozygosity may delay cognitive impairment in Alzheimer’s disease
1. Carriers of the E280A variant of presenilin 1 (PSEN1E280A) who were heterozygous for the...
Read More
Daratumumab linked to improved progression-free survival and MRD-negativity in transplant-eligible myeloma patients
1. Daratumumab in combination with bortezomib, thalidomide, and dexamethasone (D-VTd) as induction...
Read More
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced NSCLC
1. Patients with no biochemical or radiographic evidence of progressive disease had a median...
Read More
Ticagrelor and aspiring dual antiplatelet therapy is favourable over monotherapy following coronary artery bypass
1. Dual antiplatelet therapy with ticagrelor and asprin led to a significantly lower risk of major...
Read More
Heat-Induced 1.5°C Core Temperature Increase Doubles Myocardial Blood Flow in Healthy Individuals; Linked to Asymptomatic Myocardial Ischemia in CAD
1. In this randomized controlled trial, exposure to heat that increased core temperature by 1.5C...
Read More
Early asthma and COPD intervention decreases healthcare utilization
1. In this randomized controlled trial, adults with undiagnosed asthma or chronic obstructive...
Read More
#VisualAbstract: Neoadjuvant Nivolumab and Ipilimumab Improve Outcomes in Resectable Stage III Melanoma
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
Osimertinib significantly improved progression-free survival in patients with unresectable stage III non-small cell lung cancer
1. Treatment with osimertinib significantly improved progression-free survival, compared to...
Read More
Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colon Cancer
1. No disease recurrences were observed during the median follow-up time of 26.2 months. 2....
Read More
Quantifying the reduction of primary breast cancer associated with exercise
1. Across a follow-up period of approximately 5 years, there was a non-linear relationship between...
Read More
Telephone coaching program may help patients achieve weight loss
1. The addition of 3 or 12 weeks of telephone coaching for individuals with suboptimal response in...
Read More
Bimekizumab Safe and Effective for Moderate-To-Severe Hidradenitis Suppurativa Treatment
1. Significantly more patients in the bimekizumab group than placebo reported improved clinical...
Read More
Long-term survival improved with use of tebentafusp for metastatic uveal melanoma
1. Across a median follow-up of 48.5 months, usage of tebentafusp for patients with metastatic...
Read More